S Hagen

Publications (1)8.3 Total impact

• Article: Phase I and pharmacokinetic study of elacytarabine, a novel 5'-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies.

  F J Giles, N Vey, D Rizzieri, F Ravandi, T Prebet, G Borthakur, T F Jacobsen, S Hagen, B Nilsson, S O'Brien
  Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 01/2012; 26(7):1686-9. · 8.30 Impact Factor